Firering Strategic Minerals: From explorer to producer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://www.investegate.co.uk/goodbody-health-ltd--gdby-/rns/divestment-of-polish-cbd-operations/202212160700049181J/
Selling up on cbd.....
Wow. This is unexpected. So if they are selling th extraction part it also says that they will not do CBD at all anymore?
Its no surprise. It was one of the questions put to Marc. We are still selling. Did, however, sell the plant for the same value as our current market cap. Smart move
Hopefully they have negotiated a good deal with Voyager so that they can continue to offer GDBY CBD at favourable prices in the future.
I also hope that this move will show the market that they are fully committed to the clinic business and that this might activate new investors.
And do I see it right that they can acquire up to 25% of Voyager? I think that's not so bad for the future.
Interview of the Voyger CEO regarding the CBD extraction facility they bought from GDBY
https://www.proactiveinvestors.co.uk/search/advancedSearch/all?keyword=voyager+life
So let me get this straight I/we lost 2/3 of our shares for a company's assests that we have now sold? Do we still have the facilities in Romania?
No. I think that went to Dragonfly
From my perspective, no own facility anymore.
But there are a lot of questions regarding this trade still unclear. I hope GDBY will announce some more details especially for the future CBD business
And it is again just unbelievable that GDBY is not able to share this important business change for the CBD business on lse, hl and other relevant UK shareholder platforms. And in addition to that, they are also not prepared/able to directly share or set up an CEO interview which gives more context about the future CBD business approach for GDBY.
I really don't get their shareholder communication strategy anymore.
There isn't one mate, never has been. Apart from to take our shares.
Looks like they are working on a CEO video for explaining more about the current CBD business step
London Medical Labs now have 86 clinics of their own.
Nice find. Some of them are also on the list of GDBY locations.
Questions is, what LML offers. If it is just selling their test kits or is it more?
Interview from George about the extraction facility sales
https://www.youtube.com/watch?v=Xr-2Ch9xEAI&t=2s
Brilliant update. The threads that George mentioned were so encouraging. Very good
looks like he has really more drive than Marc.
Great to here that they sold the extraction plant and reduce the cost by handing it over to Voyager but the agreement with Olimax is still in place to get destillate and isolate for the same conditions.
Lets wait and figure out if they can really be part of all these different trial scenarios (NHS; device producer, research and pharma companies).
Would really be great to see forecasts in Q1 and an improvement of the shareholder communication.